Notably, in melanoma 25, the upregulation of LINC00589 has been demonstrated to restore sensitivity to the BRAF inhibitor PLX4720 in resistant cells, offering a potential therapeutic avenue for patients resistant to BRAF inhibitors. The gene discussed is BRAF; the disease is melanoma.